MedPath

Evaluation of gastrointestinal tolerance of a new thickening powder in patients with dysphagia

Completed
Conditions
Dysphagia
Signs and Symptoms
Registration Number
ISRCTN86521801
Lead Sponsor
umico Research BV (Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

1. Oropharyngeal dysphagia confirmed by the SLT using bed-side swallowing evaluation or videofluoroscopy
2. Neurogenic aetiology or caused by muscle weakness
3. Stable severity (require thickend drinks for at least 3 weeks after inclusion)
4. Written informed consent

Exclusion Criteria

1. Impaired consciousness level
2. Inadequate cognitive skills to comprehend study requirements and to communicate responses to questions
3. Bowel habit unable to be defined using the study specific gastrointestinal (GI) questionnaire
4. Enteral tube feeding corresponding to >50% of total energy intake
5. Use of any foods or fluids thickened with another commercial thickener

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gastrointestinal symptoms (measurements: stool frequency and consistency, GI symptoms and food and fluid intake).
Secondary Outcome Measures
NameTimeMethod
1. Patient product acceptability (intake thickening powder)<br>2. Carer product evaluation (product evaluation questionnaire)
© Copyright 2025. All Rights Reserved by MedPath